Biomerica, Inc. is a biomedical technology company that develops, patents, manufactures and markets advanced diagnostic and therapeutic products. Its diagnostic test kits are utilized in the analysis of blood, urine, nasal, or fecal samples for the diagnosis of various diseases, food intolerances, and other medical conditions. Its range of medical diagnostic products is sold primarily in two markets: clinical laboratories and point-of-care settings, including physicians’ offices and over-the-counter sales. It is focused on research and development efforts and is its patented diagnostic-guided therapy (DGT) product, developed on the in Foods technology platform. Its inFoods IBS product, uses a simple blood test to identify patient-specific foods that, when eliminated, may alleviate IBS symptoms such as pain, bloating, diarrhea, cramping, and constipation. Its hp+detect, a new diagnostic test for detecting Helicobacter pylori (H. pylori) bacteria in the gastrointestinal tract.
Código da empresaBMRA
Nome da EmpresaBiomerica Inc
Data de listagemMar 17, 1980
CEOMr. Zackary S. Irani
Número de funcionários63
Tipo de títulosOrdinary Share
Fim do ano fiscalMar 17
Endereço17571 Von Karman Avenue
CidadeIRVINE
Bolsa de valoresNASDAQ Capital Market Consolidated
PaísUnited States of America
Código postal92614
Telefone19493792875
Sitehttps://biomerica.com/
Código da empresaBMRA
Data de listagemMar 17, 1980
CEOMr. Zackary S. Irani
Um total de
0.00
USD foi distribuído em dividendos nos últimos 5 anos.

Sem dados